US Stock MarketDetailed Quotes

FBLG FibroBiologics

Watchlist

1.200
0.0000.00%

Trading Aug 16 12:18 ET

42.19MMarket Cap-2016P/E (TTM)

FibroBiologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

54.04%3.22M

52.32%3.45M

98.99%8.89M

90.18%2.48M

52.95%2.05M

2.09M

2.27M

183.08%4.47M

1.3M

1.34M

Selling and administrative expenses

45.47%2.25M

39.34%2.49M

96.42%6.52M

78.00%1.71M

48.74%1.48M

--1.55M

--1.79M

214.10%3.32M

--959K

--993K

-General and administrative expense

45.47%2.25M

39.34%2.49M

96.42%6.52M

78.00%1.71M

48.74%1.48M

--1.55M

--1.79M

214.10%3.32M

--959K

--993K

Research and development costs

78.24%975K

100.84%960K

106.45%2.37M

124.06%773K

64.94%574K

--547K

--478K

120.15%1.15M

--345K

--348K

Operating profit

-54.04%-3.22M

-52.32%-3.45M

-98.99%-8.89M

-90.18%-2.48M

-52.95%-2.05M

-2.09M

-2.27M

-183.08%-4.47M

-1.3M

-1.34M

Net non-operating interest income expense

750.00%65K

125.93%35K

77.52%-147K

99.55%-1K

-10K

-135K

-16,250.00%-654K

-220K

-221K

Non-operating interest income

--70K

--39K

----

--0

----

Non-operating interest expense

-50.00%5K

-97.04%4K

-77.52%147K

-99.55%1K

--0

--10K

--135K

16,250.00%654K

--220K

--221K

Other net income (expense)

7,217.54%4.06M

-33,533.33%-5.05M

-7.45M

-7.24M

-141K

-57K

-15K

Gain on sale of security

--4.03M

----

Other non- operating income (expenses)

152.63%30K

-33,533.33%-5.05M

---7.45M

---7.24M

---141K

---57K

---15K

----

Income before tax

141.57%898K

-250.31%-8.46M

-221.91%-16.49M

-537.60%-9.72M

-40.33%-2.19M

-2.16M

-2.42M

-223.70%-5.12M

-1.52M

-1.56M

Income tax

Net income

141.57%898K

-250.31%-8.46M

-221.91%-16.49M

-537.60%-9.72M

-40.33%-2.19M

-2.16M

-2.42M

-223.70%-5.12M

-1.52M

-1.56M

Net income continuous Operations

141.57%898K

-250.31%-8.46M

-221.91%-16.49M

-537.60%-9.72M

-40.33%-2.19M

---2.16M

---2.42M

-223.70%-5.12M

---1.52M

---1.56M

Minority interest income

Net income attributable to the parent company

141.57%898K

-250.31%-8.46M

-221.91%-16.49M

-537.60%-9.72M

-40.33%-2.19M

-2.16M

-2.42M

-223.70%-5.12M

-1.52M

-1.56M

Preferred stock dividends

Other preferred stock dividends

2.57M

Net income attributable to common stockholders

141.57%898K

-69.61%-8.46M

-272.15%-19.06M

-537.60%-9.72M

-40.33%-2.19M

-2.16M

-4.99M

-223.70%-5.12M

-1.52M

-1.56M

Basic earnings per share

145.11%0.03

-75.80%-0.27

-272.15%-0.5868

-537.60%-0.2992

-40.33%-0.0675

-0.0665

-0.1536

-223.71%-0.1577

-0.0469

-0.0481

Diluted earnings per share

145.11%0.03

-75.80%-0.27

-272.15%-0.5868

-537.60%-0.2992

-40.33%-0.0675

-0.0665

-0.1536

-223.71%-0.1577

-0.0469

-0.0481

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	54.04%3.22M	52.32%3.45M	98.99%8.89M	90.18%2.48M	52.95%2.05M	2.09M	2.27M	183.08%4.47M	1.3M	1.34M
Selling and administrative expenses	45.47%2.25M	39.34%2.49M	96.42%6.52M	78.00%1.71M	48.74%1.48M	--1.55M	--1.79M	214.10%3.32M	--959K	--993K
-General and administrative expense	45.47%2.25M	39.34%2.49M	96.42%6.52M	78.00%1.71M	48.74%1.48M	--1.55M	--1.79M	214.10%3.32M	--959K	--993K
Research and development costs	78.24%975K	100.84%960K	106.45%2.37M	124.06%773K	64.94%574K	--547K	--478K	120.15%1.15M	--345K	--348K
Operating profit	-54.04%-3.22M	-52.32%-3.45M	-98.99%-8.89M	-90.18%-2.48M	-52.95%-2.05M	-2.09M	-2.27M	-183.08%-4.47M	-1.3M	-1.34M
Net non-operating interest income expense	750.00%65K	125.93%35K	77.52%-147K	99.55%-1K	0	-10K	-135K	-16,250.00%-654K	-220K	-221K
Non-operating interest income	--70K	--39K	----	----	----	--0	--0	----	----	----
Non-operating interest expense	-50.00%5K	-97.04%4K	-77.52%147K	-99.55%1K	--0	--10K	--135K	16,250.00%654K	--220K	--221K
Other net income (expense)	7,217.54%4.06M	-33,533.33%-5.05M	-7.45M	-7.24M	-141K	-57K	-15K
Gain on sale of security	--4.03M	----	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	152.63%30K	-33,533.33%-5.05M	---7.45M	---7.24M	---141K	---57K	---15K	----	----	----
Income before tax	141.57%898K	-250.31%-8.46M	-221.91%-16.49M	-537.60%-9.72M	-40.33%-2.19M	-2.16M	-2.42M	-223.70%-5.12M	-1.52M	-1.56M
Income tax
Net income	141.57%898K	-250.31%-8.46M	-221.91%-16.49M	-537.60%-9.72M	-40.33%-2.19M	-2.16M	-2.42M	-223.70%-5.12M	-1.52M	-1.56M
Net income continuous Operations	141.57%898K	-250.31%-8.46M	-221.91%-16.49M	-537.60%-9.72M	-40.33%-2.19M	---2.16M	---2.42M	-223.70%-5.12M	---1.52M	---1.56M
Minority interest income
Net income attributable to the parent company	141.57%898K	-250.31%-8.46M	-221.91%-16.49M	-537.60%-9.72M	-40.33%-2.19M	-2.16M	-2.42M	-223.70%-5.12M	-1.52M	-1.56M
Preferred stock dividends
Other preferred stock dividends	0	0	2.57M	0	0	0	2.57M	0	0	0
Net income attributable to common stockholders	141.57%898K	-69.61%-8.46M	-272.15%-19.06M	-537.60%-9.72M	-40.33%-2.19M	-2.16M	-4.99M	-223.70%-5.12M	-1.52M	-1.56M
Basic earnings per share	145.11%0.03	-75.80%-0.27	-272.15%-0.5868	-537.60%-0.2992	-40.33%-0.0675	-0.0665	-0.1536	-223.71%-0.1577	-0.0469	-0.0481
Diluted earnings per share	145.11%0.03	-75.80%-0.27	-272.15%-0.5868	-537.60%-0.2992	-40.33%-0.0675	-0.0665	-0.1536	-223.71%-0.1577	-0.0469	-0.0481
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall